More about

Central Nervous System

News
August 07, 2024
2 min read
Save

Questionnaire reliably measures nociplastic pain across musculoskeletal conditions

Questionnaire reliably measures nociplastic pain across musculoskeletal conditions

An eight-item questionnaire, called Central Aspects of Pain, reliably measures nociplastic pain across a variety of chronically painful musculoskeletal conditions, according to data published in Rheumatology.

Clinical Guidance
Multiple Sclerosis
Presentation and Diagnosis

Critical Diagnostic Criteria

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Multiple Sclerosis
Overview

Etiology and Risk Factors

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Multiple Sclerosis
Overview

Definition and Classification

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
April 05, 2024
1 min read
Save

Collaboration to advance small activating RNA therapeutics for central nervous system

Collaboration to advance small activating RNA therapeutics for central nervous system

A London-based biotech firm has announced a collaboration and licensing agreement with a Japanese pharmaceutical firm for discovery, development and commercialization of small activating RNA therapeutics for rare neurodegenerative diseases.

News
April 04, 2024
1 min read
Save

Neurosurgical ablation system receives limited commercial launch

Neurosurgical ablation system receives limited commercial launch

A Minnesota-based medical technology company announced a limited commercial launch of its OneRF Ablation System, which creates radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

News
March 21, 2024
1 min read
Save

Clemastine fumarate linked to accelerated disability progression in MS

Clemastine fumarate linked to accelerated disability progression in MS

WEST PALM BEACH, Fla. — Treatment with clemastine fumarate was linked to accelerated disease and disability progression due to pyroptosis in a small cohort of individuals with multiple sclerosis, according to a presenter at ACTRIMS 2024.

News
February 27, 2024
1 min read
Save

Neurodiagnostics company receives US patent for electrode interface device

Neurodiagnostics company receives US patent for electrode interface device

A firm specializing in brain-computer interface has received a U.S. patent for its Medusa Electrode, which translates specific neuromodulation connections into universal electroencephalography plugs.

News
February 05, 2024
1 min read
Save

Medical device firm secures $85M to advance CNS-based chronic pain system

Medical device firm secures $85M to advance CNS-based chronic pain system

An Ohio-based medical device company has secured $85 million in financing to advance a pain management system targeting the central nervous system to help those who have undergone surgery or sustained damage from other events or conditions.

News
December 28, 2023
5 min read
Save

AAV-based gene therapies hold promise for treating CNS conditions

AAV-based gene therapies hold promise for treating CNS conditions

Meaningful progress is being made in the development of gene therapies for rare neurological diseases caused by single gene mutations.

View more